RAG2 and B-cell non-Hodgkin lymphoma: To determine whether the therapeutic effects of Vγ9Vδ2-T cells on EBV-induced B cell lymphoma were inhibited by IL-10 within the TME, EBV-LCL1 expressing low levels of IL-10 (IL-10low LCL) and EBV-LCL6 expressing high levels of IL-10 (IL-10high LCL) were inoculated into Rag2-/- γc-/- mice, respectively (Figure 2A).